相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Embracing proteins: structural themes in aptamer-protein complexes
Amy D. Gelinas et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy
Lillian L. Smith et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Evolution of thermophilic DNA polymerases for the recognition and amplification of C2′-modified DNA
Tingjian Chen et al.
NATURE CHEMISTRY (2016)
An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein
Vinita Gupta et al.
BIOANALYSIS (2016)
An L-RNA Aptamer that Binds and Inhibits RNase
Charles Olea et al.
CHEMISTRY & BIOLOGY (2015)
Understanding PCSK9 and anti-PCSK9 therapies
James M. McKenney
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
RNA therapeutics inactivate PCSK9 by inducing a unique intracellular retention form
Cristina S. J. Rocha et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
John C. Rohloff et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2015)
Non-helical DNA Triplex Forms a Unique Aptamer Scaffold for High Affinity Recognition of Nerve Growth Factor
Thale C. Jarvis et al.
STRUCTURE (2015)
Array-based Discovery of Aptamer Pairs
Minseon Cho et al.
ANALYTICAL CHEMISTRY (2015)
Catalysts from synthetic genetic polymers
Alexander I. Taylor et al.
NATURE (2015)
Systematic selection of modified aptamer pairs for diagnostic sandwich assays
Urs A. Ochsner et al.
BIOTECHNIQUES (2014)
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
Qiurong Ding et al.
CIRCULATION RESEARCH (2014)
Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand
Amy D. Gelinas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
Shashi Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
In vitro selection with artificial expanded genetic information systems
Kwame Sefah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents
John C. Rohloff et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Anti-PCSK9 therapies for the treatment of hypercholesterolemia
Amanda J. Hooper et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Structural analysis of B-cell epitopes in antibody:protein complexes
Jens Vindahl Kringelum et al.
MOLECULAR IMMUNOLOGY (2013)
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Michiko Kimoto et al.
NATURE BIOTECHNOLOGY (2013)
Selection Strategy to Generate Aptamer Pairs that Bind to Distinct Sites on Protein Targets
Qiang Gong et al.
ANALYTICAL CHEMISTRY (2012)
Antigen-antibody interface properties: Composition, residue interactions, and features of 53 non-redundant structures
Thiruvarangan Ramaraj et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
The biology and therapeutic targeting of the proprotein convertases
Nabil G. Seidah et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Efficient Reverse Transcription Using Locked Nucleic Acid Nucleotides towards the Evolution of Nuclease Resistant RNA Aptamers
Lucile Crouzier et al.
PLOS ONE (2012)
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets
Douglas R. Davies et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Synthetic Genetic Polymers Capable of Heredity and Evolution
Vitor B. Pinheiro et al.
SCIENCE (2012)
Effects of the Prosegment and pH on the Activity of PCSK9 EVIDENCE FOR ADDITIONAL PROCESSING EVENTS
Suzanne Benjannet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Expanding the Chemistry of DNA for in Vitro Selection
Jonathan D. Vaught et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
Genetic and Metabolic Determinants of Plasma PCSK9 Levels
Susan G. Lakoski et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Investigation of the Catalytic Mechanism of a Synthetic DNAzyme with Protein-like Functionality: An RNaseA Mimic?
Jason M. Thomas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
Joyce C. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effect of mutations in the PCSK9 gene on the cell surface LDL receptors
J Cameron et al.
HUMAN MOLECULAR GENETICS (2006)
Molecular recognition by a binary code
FA Fellouse et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia
XM Sun et al.
HUMAN MOLECULAR GENETICS (2005)
Sequence-specific cleavage of RNA in the absence of divalent metal ions by a DNAzyme incorporating imidazolyl and amino functionalities
AV Sidorov et al.
NUCLEIC ACIDS RESEARCH (2004)
A novel, modification-dependent ATP-binding aptamer selected from an RNA library incorporating a cationic functionality
NK Vaish et al.
BIOCHEMISTRY (2003)
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
M Abifadel et al.
NATURE GENETICS (2003)
Generation of species cross-reactive aptamers using toggle SELEX
R White et al.
MOLECULAR THERAPY (2001)
RNA cleavage by a DNA enzyme with extended chemical functionality
SW Santoro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
分享论文
